Search results
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 4 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Feeling Sick After Your COVID Vaccine? According to Scientists, It’s Actually a Good Sign
SciTechDaily· 5 days agoA UCSF study suggests that side effects like headaches and chills from COVID-19 vaccines indicate a...
Feds try to delay release of non-public COVID vaccine safety data until at least 2026
Just the News· 5 days agoThe Biden administration is seeking to delay until at least 2026 the release of COVID-19 vaccine...
...NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID...
NewMediaWire via Yahoo Finance· 6 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen, ...
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool via Yahoo Finance· 2 days agoEven if that target proves overly optimistic, much of the negative impact of the patent cliff could be offset by these new products and indications. ...
3 No-Brainer Stocks to Buy for Under $100 Right Now
The Motley Fool via AOL· 2 days agoEven if that target proves overly optimistic, much of the negative impact of the patent cliff could be offset by these new products and indications. Pfizer built a massive ...
Gateway - Quartz
Quartz· 1 week agoIs the covid pandemic over? The World Health Organization (WHO) is set to consider that question at a meeting this week, its 14th since the UN agency first identified the ...
What new laws go into effect in Kansas on July 1, 2024?
KSNT Topeka· 7 days agoTOPEKA (KSNT) – Lawmakers successfully passed more than a hundred new laws for Kansas this year with...
Gateway - The Root
The Root· 6 days agoHealth experts in Mississippi and the federal level are urging residents in the state not to ingest ivermectin to treat COVID-19. In case you wanna know what ivermectin is ...
3 No-Brainer Stocks to Buy for Under $100 Right Now | The Motley Fool
The Motley Fool· 2 days agoHere's why they picked AstraZeneca (AZN 0.41%), Bristol Myers Squibb (BMY 2.17%), and Pfizer (PFE)....
